2022 FIA Formula 2 World Champion Felipe Drugovich has landed an NTT IndyCar Series testing opportunity with reigning champions Chip Ganassi Racing.
Drugovich has served as Aston Martin’s Formula 1 Test and Reserve Driver since graduating from F2 at the end of 2022.
In 2024, the Brazilian balanced his testing duties with a European Le Mans Series campaign with Vector Sport and contested this year’s 24 Hours of Le Mans with Action Express Racing’s Cadilac V-Series.R.
Now Drugovich will test an IndyCar with Ganassi at Barber Motorsports Park on September 30.
“We’ve received approval today from IndyCar to test him,” said CGR managing director Mike Hull via RACER.
“With the way IndyCar has the testing rules structured to test and evaluate drivers, it made sense to connect with Felipe and get him in one of our cars.”
Hull revealed the test is Chip Ganassi delivering on a promise to Drugovich.
Chip Ganassi saw Drugovich up close at Le Mans, with the team running the factory Cadillac effort in competition with Action Express.
“We wanted to test him a year ago and we’re catching up on that,” Hull said.
“Indirectly, we were introduced to Drugovich last year at Le Mans and were impressed with him up close and personal.
“We want to get to know him and we think it’s worth doing.”
Felipe Drugovich IndyCar race seat prospects slim
Chip Ganassi is downsizing from a five-car to a three-car effort in 2025 making a race seat opportunity unlikely for Drugovich.
Scott Dixon and 2024 IndyCar Champion Alex Palou are the only two confirmed drivers for Chip Ganassi in 2025.
Marcus Armstrong has departed for Meyer Shank Racing with Linus Lundqvist and Kyffin Simpson still looking for a drive.
As a result, Drugovich’s opportunities look remote.
“There were no strings attached to that one,” Hull revealed to Autosport.
“Certainly, nothing to this one. Where is it gonna go? Right now, it doesn’t have legs.”
READ MORE: Meyer Shank Racing sign Marcus Armstrong for 2025 IndyCar campaign
